Amgen's weight-loss drug MariTide had a successful Phase 2 trial so the company is expanding development plans to study its use for heart disease and sleep apnea.

A research study led by Professor Tarani Chandola from the Department of Sociology, Faculty of Social Sciences at the ...

While the longevity industry promotes costly interventions like full-body scans, supplement stacks, and elite wellness ...

A new multi-cohort study at Columbia University Mailman School of Public Health has found that exposure to certain metals, ...

In a new observational study, researchers from the Gerald J. and Dorothy R. Friedman School of Nutrition Science and Policy ...